Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 An HIV Diagnosis, Option Assessment Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9a-0501. Case and Commentary Jan 2005 An HIV Diagnosis, Option Comparison Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9b-0501. Case and Commentary Jan 2005 An HIV Diagnosis, Additional Information Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9c-0501. Case and Commentary Dec 2009 The Challenges of Treating Patients with Multiple Diagnoses R. Douglas Bruce, MD, MA, MSc Strategies for designing treatment programs for patients with triple diagnoses—HIV, schizophrenia, and opioid dependence. Virtual Mentor. 2009;11(12):944-948. doi: 10.1001/virtualmentor.2009.11.12.ccas3-0912. Podcast May 2024 Author Interview: "How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?” Dr Majd Alsoubani joins Ethics Talk to discuss her article, coauthored with Drs Maya Nadimpalli and Shira Doron: "How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?” Medicine and Society May 2024 How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers? Majd Alsoubani, MD, Maya L. Nadimpalli, PhD, MS, and Shira Doron, MD Antimicrobial resistance is a looming pandemic, and poor health outcomes will not be borne equitably. AMA J Ethics. 2024;26(5):E383-389. doi: 10.1001/amajethics.2024.383. Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Case and Commentary Jan 2005 An HIV Diagnosis, Option Assessment Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9a-0501.
Case and Commentary Jan 2005 An HIV Diagnosis, Option Comparison Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9b-0501.
Case and Commentary Jan 2005 An HIV Diagnosis, Additional Information Abraham P. Schwab, MA Virtual Mentor. 2005;7(1):48-52. doi: 10.1001/virtualmentor.2005.7.1.ccas9c-0501.
Case and Commentary Dec 2009 The Challenges of Treating Patients with Multiple Diagnoses R. Douglas Bruce, MD, MA, MSc Strategies for designing treatment programs for patients with triple diagnoses—HIV, schizophrenia, and opioid dependence. Virtual Mentor. 2009;11(12):944-948. doi: 10.1001/virtualmentor.2009.11.12.ccas3-0912.
Podcast May 2024 Author Interview: "How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?” Dr Majd Alsoubani joins Ethics Talk to discuss her article, coauthored with Drs Maya Nadimpalli and Shira Doron: "How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?”
Medicine and Society May 2024 How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers? Majd Alsoubani, MD, Maya L. Nadimpalli, PhD, MS, and Shira Doron, MD Antimicrobial resistance is a looming pandemic, and poor health outcomes will not be borne equitably. AMA J Ethics. 2024;26(5):E383-389. doi: 10.1001/amajethics.2024.383.
Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367.